CRISPR Can Help The Switch To Sustainable Cosmetics
The cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According…
16/05/2022 - 5 minutes
CRISPR: A Promising Industry With Many Questions Unanswered
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
Show More
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportLatest CRISPR Articles
UK Startup Lands €5M Seed Round to Produce Gene-Edited Crops with AI
Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited…
17/12/2021 - 4 minutes
CRISPR-Cas9: The Gene Editing Tool Changing the World
CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much…
03/11/2021 - 11 minutes
Gene-Edited T Cell Therapy Players Battle Safety Doubts
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
22/10/2021 - 5 minutes
Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
13/09/2021 - 10 minutes
Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
04/05/2021 - 5 minutes
The Promises of CRISPR Genome Editing in Biomedicine
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
03/03/2021 - 5 minutes
Sponsored
by Synthego
Can Better Disease Modeling Help Fight Neurological Diseases?
The prevalence of neurological diseases has increased rapidly, and they are now the second biggest…
17/02/2021 - 6 minutes
Sponsored
by Leaps by Bayer
Ethics, Investment, and What Comes Next in Gene-Editing Technologies
As next-generation gene-editing technologies become increasingly popular, biotech industry stakeholders carry the responsibility to ensure…
11/01/2021 - 5 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
GMO Regulations in Europe Are “Not Fit for Purpose”
The controversial decision by the European courts in 2018 to regulate gene-edited organisms as GMOs…
11/11/2020 - 8 minutes
2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…
09/10/2020 - 4 minutes
